Medtronic Acquires Covidien for $42.9B in Cash & Stock

June 19, 2014
As a direct benefit of the company's new financial structure, Medtronic will commit to $10 billion in technology investments over the next 10 years in areas such as early stage venture capital investments, acquisitions, and R&D in the U.S., above and beyond Medtronic's and Covidien's existing plans.
Previous Article
NBMC Picks Wearable Sensor Patch Subsystem Project

The Nano-Bio Manufacturing Consortium (NBMC) has selected a proposal by the...

Next Article
China's Urbanization Plan: New Opportunities, Big Challenges

The country's high-speed economic expansion over the past three decades has...